Co-Authors
This is a "connection" page, showing publications co-authored by Sven Saussez and Jerome Lechien.
Connection Strength
48.657
-
COVID-19: Post-vaccine Smell and Taste Disorders: Report of 6 Cases. Ear Nose Throat J. 2021 Sep 01; 1455613211033125.
Score: 0.965
-
Importance of epidemiological factors in the evaluation of transmissibility and clinical severity of SARS-CoV-2 variants. Lancet Infect Dis. 2022 01; 22(1):2-3.
Score: 0.964
-
Correction to: Epidemiological, otolaryngological, olfactory and gustatory outcomes according to the severity of COVID-19: a study of 2579 patients. Eur Arch Otorhinolaryngol. 2021 Aug; 278(8):2861.
Score: 0.959
-
Psychophysical evaluations are important, usefulness and usability approaches to study the smell disorder related to COVID-19. J Intern Med. 2021 08; 290(2):468-469.
Score: 0.950
-
Short-Term Efficacy and Safety of Oral and Nasal Corticosteroids in COVID-19 Patients with Olfactory Dysfunction: A European Multicenter Study. Pathogens. 2021 Jun 04; 10(6).
Score: 0.949
-
The interest of fluticasone nasal spray in COVID-19 related anosmia is still not demonstrated. Am J Otolaryngol. 2021 Jul-Aug; 42(4):103008.
Score: 0.936
-
Clinical features of patients who had two COVID-19 episodes: a European multicentre case series. J Intern Med. 2021 Aug; 290(2):421-429.
Score: 0.934
-
Pathophysiological mechanisms and management of patients with long-time anosmia related to COVID-19. J Intern Med. 2021 08; 290(2):464-465.
Score: 0.930
-
Epidemiological, otolaryngological, olfactory and gustatory outcomes according to the severity of COVID-19: a study of 2579 patients. Eur Arch Otorhinolaryngol. 2021 Aug; 278(8):2851-2859.
Score: 0.924
-
Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients. J Intern Med. 2021 Aug; 290(2):451-461.
Score: 0.922
-
Severity of Anosmia as an Early Symptom of COVID-19 Infection May Predict Lasting Loss of Smell. Front Med (Lausanne). 2020; 7:582802.
Score: 0.915
-
ACE2 & TMPRSS2 Expressions in Head & Neck Tissues: A Systematic Review. Head Neck Pathol. 2021 Mar; 15(1):225-235.
Score: 0.898
-
Clinical and Radiological Evaluations of COVID-19 Patients With Anosmia: Preliminary Report. Laryngoscope. 2020 11; 130(11):2526-2531.
Score: 0.897
-
Sniffing out the evidence; It's now time for public health bodies recognize the link between COVID-19 and smell and taste disturbance. Rhinology. 2020 Aug 01; 58(4):402-403.
Score: 0.895
-
Objective Olfactory Findings in Hospitalized Severe COVID-19 Patients. Pathogens. 2020 Jul 31; 9(8).
Score: 0.895
-
In Reference to Anosmia and Ageusia: Common Findings in COVID-19 Patients. Laryngoscope. 2020 09; 130(9):E504-E505.
Score: 0.890
-
Gustatory dysfunctions in COVID-19. Eur Arch Otorhinolaryngol. 2020 08; 277(8):2397-2398.
Score: 0.889
-
Letter to the Editor about the Beltrán-Corbellini et al. publication: 'Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study' (Eur J Neurol 2020. doi: 10.1111/ene.14273). Eur J Neurol. 2020 09; 27(9):e33.
Score: 0.888
-
The association between laryngopharyngeal reflux and COVID-19 is still not demonstrated. J Med Virol. 2020 11; 92(11):2392-2393.
Score: 0.886
-
Features of Mild-to-Moderate COVID-19 Patients With Dysphonia. J Voice. 2020 Jun 04.
Score: 0.885
-
Patient-Reported Outcome Questionnaires for the evaluation of olfactory and gustatory dysfunctions in COVID-19. Eur Arch Otorhinolaryngol. 2020 08; 277(8):2393-2394.
Score: 0.885
-
Psychophysical Olfactory Tests and Detection of COVID-19 in Patients With Sudden Onset Olfactory Dysfunction: A Prospective Study. Ear Nose Throat J. 2020 Nov; 99(9):579-583.
Score: 0.884
-
Loss of Smell and Taste in 2013 European Patients With Mild to Moderate COVID-19. Ann Intern Med. 2020 10 20; 173(8):672-675.
Score: 0.884
-
Anosmia Is a Key Symptom of COVID-19 Infection and Should Be Used as a Diagnostic Tool. Ear Nose Throat J. 2020 Nov; 99(9):577-578.
Score: 0.883
-
Objective olfactory evaluation of self-reported loss of smell in a case series of 86 COVID-19 patients. Head Neck. 2020 Jul; 42(7):1583-1590.
Score: 0.883
-
Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020 Aug; 277(8):2251-2261.
Score: 0.876
-
Treatment of laryngopharyngeal reflux disease: A systematic review. World J Clin Cases. 2019 Oct 06; 7(19):2995-3011.
Score: 0.846
-
Clinical and Acoustical Voice Quality Evolutions Throughout Empirical Treatment for Laryngopharyngeal Reflux Disease According to Gender: A Preliminary Study. Folia Phoniatr Logop. 2020; 72(4):257-266.
Score: 0.825
-
Alkaline, protein, low-fat and low-acid diet in laryngopharyngeal reflux disease: Our experience on 65 patients. Clin Otolaryngol. 2019 05; 44(3):379-384.
Score: 0.804
-
Laryngopharyngeal reflux and benign lesions of the vocal folds. Eur Arch Otorhinolaryngol. 2019 Jan; 276(1):277-278.
Score: 0.796
-
Instruments evaluating the clinical findings of laryngopharyngeal reflux: A systematic review. Laryngoscope. 2019 03; 129(3):720-736.
Score: 0.789
-
The Effect of the Speech Task Characteristics on Perceptual Judgment of Mild to Moderate Dysphonia: A Methodological Study. Folia Phoniatr Logop. 2018; 70(3-4):156-164.
Score: 0.783
-
The development of new clinical instruments in laryngopharyngeal reflux disease: The international project of young otolaryngologists of the International Federation of Oto-rhino-laryngological Societies. Eur Ann Otorhinolaryngol Head Neck Dis. 2018 Sep; 135(5S):S85-S91.
Score: 0.783
-
Total Pharyngo-esophageal Stenosis: A New Surgical Procedure Using Modified Retrograde Transillumination Approach. Surg Laparosc Endosc Percutan Tech. 2018 Aug; 28(4):e75-e77.
Score: 0.779
-
Impact of Laryngopharyngeal Reflux on Subjective, Aerodynamic, and Acoustic Voice Assessments of Responder and Nonresponder Patients. J Voice. 2019 Nov; 33(6):929-939.
Score: 0.779
-
Change of signs, symptoms and voice quality evaluations throughout a 3- to 6-month empirical treatment for laryngopharyngeal reflux disease. Clin Otolaryngol. 2018 10; 43(5):1273-1282.
Score: 0.771
-
In response to Double-blind, placebo-controlled study with alginate suspension for laryngopharyngeal reflux disease. Laryngoscope. 2018 10; 128(10):E349-E350.
Score: 0.761
-
Gender differences in the presentation of dysphonia related to laryngopharyngeal reflux disease: a case-control study. Eur Arch Otorhinolaryngol. 2018 Jun; 275(6):1513-1524.
Score: 0.761
-
Voice quality outcomes of idiopathic Parkinson's disease medical treatment: A systematic review. Clin Otolaryngol. 2018 06; 43(3):882-903.
Score: 0.759
-
Image analysis of the interarytenoid area to detect laryngopharyngeal reflux disease. Am J Otolaryngol. 2018 Mar - Apr; 39(2):228-229.
Score: 0.749
-
Contact allergy to benzalkonium chloride in patients using a steroid nasal spray: A report of 3 cases. Ear Nose Throat J. 2018 Jan-Feb; 97(1-2):E20-E22.
Score: 0.749
-
Reply to the letter "Laryngopharyngeal reflux disease in the elderly". Eur Arch Otorhinolaryngol. 2018 01; 275(1):317-318.
Score: 0.745
-
Acrokeratosis paraneoplastica (Bazex syndrome). Ear Nose Throat J. 2017 Oct-Nov; 96(10-11):413-414.
Score: 0.736
-
Impact of age on laryngopharyngeal reflux disease presentation: a multi-center prospective study. Eur Arch Otorhinolaryngol. 2017 Oct; 274(10):3687-3696.
Score: 0.725
-
Impact of Chemoradiation After Supra- or Infrahyoid Cancer on Aerodynamic, Subjective, and Objective Voice Assessments: A Multicenter Prospective Study. J Voice. 2018 Mar; 32(2):257.e11-257.e19.
Score: 0.717
-
Unusual presentation of an adult pedunculated hemangioma of the oropharynx. Clin Case Rep. 2017 04; 5(4):491-496.
Score: 0.707
-
Unusual case of chronic maxillary rhinosinusitis. Ear Nose Throat J. 2017 Mar; 96(3):100-104.
Score: 0.706
-
Validity and Reliability of a French Version of Reflux Symptom Index. J Voice. 2017 Jul; 31(4):512.e1-512.e7.
Score: 0.699
-
Giant metastasis invading pharyngeal wall, pterygomaxillary space, submaxillary and parotid glands. Rev Laryngol Otol Rhinol (Bord). 2015; 136(4):167-8.
Score: 0.608
-
The study of recovery rates of COVID-19 olfactory and gustatory dysfunctions requires psychophysical evaluations. Am J Otolaryngol. 2021 Nov-Dec; 42(6):103168.
Score: 0.240
-
Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction. Eur J Neurol. 2021 11; 28(11):3702-3711.
Score: 0.239
-
Making scents of loss of taste in COVID-19: Is self-reported loss of taste due to olfactory dysfunction? A prospective study using psychophysical testing. Int Forum Allergy Rhinol. 2021 10; 11(10):1504-1507.
Score: 0.237
-
Chemosensory dysfunction in COVID-19: Is there really a correlation with viral load? Am J Otolaryngol. 2021 Jul-Aug; 42(4):103037.
Score: 0.235
-
Validity and reliability of the COVID-19 symptom index, an instrument evaluating severity of general and otolaryngological symptoms. Acta Otolaryngol. 2021 Jun; 141(6):615-620.
Score: 0.234
-
Psychophysical Evaluation of the Olfactory Function: European Multicenter Study on 774 COVID-19 Patients. Pathogens. 2021 Jan 12; 10(1).
Score: 0.231
-
More that ACE2? NRP1 may play a central role in the underlying pathophysiological mechanism of olfactory dysfunction in COVID-19 and its association with enhanced survival. Med Hypotheses. 2021 Jan; 146:110406.
Score: 0.229
-
COVID-19 Reinfection and Second Episodes of Olfactory and Gustatory Dysfunctions: Report of First Cases. Ear Nose Throat J. 2020 Nov 10; 145561320970105.
Score: 0.228
-
Anosmia: an evolution of our understanding of its importance in COVID-19 and what questions remain to be answered. Eur Arch Otorhinolaryngol. 2021 Jul; 278(7):2187-2191.
Score: 0.225
-
ACE2 Protein Landscape in the Head and Neck Region: The Conundrum of SARS-CoV-2 Infection. Biology (Basel). 2020 Aug 18; 9(8).
Score: 0.225
-
Patterns of smell recovery in 751 patients affected by the COVID-19 outbreak. Eur J Neurol. 2020 11; 27(11):2318-2321.
Score: 0.224
-
Patterns of Gustatory Recovery in Patients Affected by the COVID-19 Outbreak. Virol Sin. 2020 12; 35(6):833-837.
Score: 0.224
-
Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med. 2020 09; 288(3):335-344.
Score: 0.222
-
Olfactory and gustatory dysfunctions in COVID-19. First reports of Latin-American ethnic patients. Am J Otolaryngol. 2020 Sep - Oct; 41(5):102605.
Score: 0.221
-
Parotitis-Like Symptoms Associated with COVID-19, France, March-April 2020. Emerg Infect Dis. 2020 Sep; 26(9).
Score: 0.221
-
[The alteration of smell and taste in COVID-19 patients. A diagnostic resource in primary care]. Aten Primaria. 2020 10; 52(8):592-593.
Score: 0.221
-
Severe acute respiratory syndrome coronavirus 2: virus mutations in specific European populations. New Microbes New Infect. 2020 Jul; 36:100696.
Score: 0.221
-
Are the Acoustic Measurements Reliable in the Assessment of Voice Quality? A Methodological Prospective Study. J Voice. 2021 Mar; 35(2):203-215.
Score: 0.211
-
An unusual cause of obstructive sleep apnea syndrome. Clin Case Rep. 2019 Sep; 7(9):1694-1696.
Score: 0.209
-
Surgical Treatment for Laryngopharyngeal Reflux Disease: A Systematic Review. JAMA Otolaryngol Head Neck Surg. 2019 07 01; 145(7):655-666.
Score: 0.208
-
Infiltration of FoxP3+ Regulatory T Cells is a Strong and Independent Prognostic Factor in Head and Neck Squamous Cell Carcinoma. Cancers (Basel). 2019 Feb 15; 11(2).
Score: 0.202
-
In Reference to Saliva Pepsin Detection and Proton Pump Inhibitor Response in Suspected Laryngopharyngeal Reflux. Laryngoscope. 2019 04; 129(4):E118-E119.
Score: 0.201
-
Involvement of HPV Infection in the Release of Macrophage Migration Inhibitory Factor in Head and Neck Squamous Cell Carcinoma. J Clin Med. 2019 Jan 10; 8(1).
Score: 0.201
-
Clinical outcomes of laryngopharyngeal reflux treatment: A systematic review and meta-analysis. Laryngoscope. 2019 05; 129(5):1174-1187.
Score: 0.200
-
Laryngopharyngeal reflux disease: clinical presentation, diagnosis and therapeutic challenges in 2018. Curr Opin Otolaryngol Head Neck Surg. 2018 Dec; 26(6):392-402.
Score: 0.199
-
High infiltration of CD68+ macrophages is associated with poor prognoses of head and neck squamous cell carcinoma patients and is influenced by human papillomavirus. Oncotarget. 2018 Feb 16; 9(13):11046-11059.
Score: 0.188
-
Hibernoma: a rare case of adipocytic tumor in head and neck. BMC Ear Nose Throat Disord. 2017; 17:13.
Score: 0.187
-
Laryngopharyngeal Reflux and Voice Disorders: A Multifactorial Model of Etiology and Pathophysiology. J Voice. 2017 Nov; 31(6):733-752.
Score: 0.178
-
High stromal Foxp3-positive T cell number combined to tumor stage improved prognosis in head and neck squamous cell carcinoma. Oral Oncol. 2017 04; 67:183-191.
Score: 0.178
-
Specific Therapy of Olfactory Disorders in COVID-19 Patients is Essential for the Prevention of Long-term Dysfunction. Indian J Otolaryngol Head Neck Surg. 2021 Aug 22; 1-2.
Score: 0.060
-
Correlations Between Olfactory Psychophysical Scores and SARS-CoV-2 Viral Load in COVID-19 Patients. Laryngoscope. 2021 10; 131(10):2312-2318.
Score: 0.060
-
Analysis of the correlations between the severity of lung involvement and olfactory psychophysical scores in coronavirus disease 2019 (COVID-19) patients. Int Forum Allergy Rhinol. 2022 01; 12(1):103-107.
Score: 0.060
-
Correction to: Sinus and anterior skull base surgery during the COVID-19 pandemic: systematic review, synthesis and YO-IFOS position. Eur Arch Otorhinolaryngol. 2021 Jul; 278(7):2661.
Score: 0.060
-
Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation? J Laryngol Otol. 2021 Aug; 135(8):723-728.
Score: 0.060
-
Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study. Eur Arch Otorhinolaryngol. 2022 Feb; 279(2):811-816.
Score: 0.059
-
Six-month smell and taste recovery rates in coronavirus disease 2019 patients: a prospective psychophysical study. J Laryngol Otol. 2021 May; 135(5):436-441.
Score: 0.059
-
Efficacy of corticosteroid therapy in the treatment of long- lasting olfactory disorders in COVID-19 patients. Rhinology. 2021 Feb 01; 59(1):21-25.
Score: 0.058
-
Six month follow-up of self-reported loss of smell during the COVID-19 pandemic. Rhinology. 2021 Feb 01; 59(1):26-31.
Score: 0.058
-
Subjective evaluation of smell and taste dysfunction in patients with mild COVID-19 in Spain. Med Clin (Engl Ed). 2021 Jan 22; 156(2):61-64.
Score: 0.057
-
Olfactory epithelium histopathological findings in long-term coronavirus disease 2019 related anosmia. J Laryngol Otol. 2020 Dec; 134(12):1123-1127.
Score: 0.057
-
Predictive Accuracy of COVID-19 World Health Organization (WHO) Severity Classification and Comparison with a Bayesian-Method-Based Severity Score (EPI-SCORE). Pathogens. 2020 Oct 24; 9(11).
Score: 0.057
-
Gustatory Dysfunction: A Highly Specific and Smell-Independent Symptom of COVID-19. Indian J Otolaryngol Head Neck Surg. 2020 Sep 30; 1-3.
Score: 0.057
-
[Subjective evaluation of smell and taste dysfunction in patients with mild COVID-19 in Spain]. Med Clin (Barc). 2021 01 22; 156(2):61-64.
Score: 0.057
-
Safety and Impact of Nasal Lavages During Viral Infections Such as SARS-CoV-2. Ear Nose Throat J. 2021 Apr; 100(2_suppl):188S-191S.
Score: 0.056
-
Smell and taste recovery in coronavirus disease 2019 patients: a 60-day objective and prospective study. J Laryngol Otol. 2020 Aug; 134(8):703-709.
Score: 0.056
-
Do olfactory and gustatory psychophysical scores have prognostic value in COVID-19 patients? A prospective study of 106 patients. J Otolaryngol Head Neck Surg. 2020 Aug 06; 49(1):56.
Score: 0.056
-
A structural equation model to examine the clinical features of mild-to-moderate COVID-19: A multicenter Italian study. J Med Virol. 2021 02; 93(2):983-994.
Score: 0.056
-
Magnetic resonance imaging of COVID-19 anosmic patients reveals abnormalities of the olfactory bulb: Preliminary prospective study. J Infect. 2020 11; 81(5):816-846.
Score: 0.056
-
Remote psychophysical evaluation of olfactory and gustatory functions in early-stage coronavirus disease 2019 patients: the Bologna experience of 300 cases. J Laryngol Otol. 2020 Jul; 134(7):571-576.
Score: 0.056
-
Sinus and anterior skull base surgery during the COVID-19 pandemic: systematic review, synthesis and YO-IFOS position. Eur Arch Otorhinolaryngol. 2021 Jun; 278(6):1733-1742.
Score: 0.056
-
MRI of Patients Infected With COVID-19 Revealed Cervical Lymphadenopathy. Ear Nose Throat J. 2021 Jan; 100(1):26-28.
Score: 0.056
-
Ethyl alcohol threshold test: a fast, reliable and affordable olfactory Assessment tool for COVID-19 patients. Eur Arch Otorhinolaryngol. 2020 Oct; 277(10):2783-2792.
Score: 0.056
-
Systematic review of international guidelines for tracheostomy in COVID-19 patients. Oral Oncol. 2020 09; 108:104844.
Score: 0.055